Pharnext SAS Revenue and Competitors
Estimated Revenue & Valuation
- Pharnext SAS's estimated annual revenue is currently $4M per year.
- Pharnext SAS's estimated revenue per employee is $155,000
Employee Data
- Pharnext SAS has 26 Employees.
- Pharnext SAS grew their employee count by -33% last year.
Pharnext SAS's People
| Name | Title | Email/Phone |
|---|
Pharnext SAS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4M | 26 | -30% | N/A | N/A |
#2 | $5.9M | 38 | 9% | N/A | N/A |
#3 | $3.4M | 22 | 0% | N/A | N/A |
#4 | $1.2M | 15 | -62% | €100.3M | N/A |
#5 | $14.7M | 95 | 1% | $121M | N/A |
#6 | $3.3M | 21 | -19% | N/A | N/A |
#7 | $10.1M | 65 | 18% | N/A | N/A |
#8 | $4.2M | 27 | 17% | $6.56M | N/A |
#9 | $6.7M | 43 | 10% | N/A | N/A |
#10 | $4M | 26 | -33% | N/A | N/A |
What Is Pharnext SAS?
Pharnext is an advanced, clinical-stage biopharmaceutical company founded by renowned scientists and entrepreneurs including Professor Daniel Cohen, a pioneer in modern genomics. Pharnext has two lead products in clinical development. PXT3003 is currently in an international Phase 3 trial for the treatment of Charcot-Marie-Tooth disease type 1A and benefits from orphan drug status in Europe and the United States. PXT864 has generated positive Phase 2 results in Alzheimer's disease. Pharnext is the pioneer of a new drug discovery paradigm: PLEOTHERAPYâ„¢. The Company identifies and develops synergic combinations of repositioned drugs at low dose. These PLEODRUGâ„¢ offer several key advantages: efficacy, safety and intellectual property including several product or composition of matter patents already granted. The Company is supported by a world-class scientific team. The company Pharnext is listed on Euronext Alternext Stock Exchange in Paris (ISIN code: FR00111911287). For more information, visit www.pharnext.com
keywords:N/A
N/A
Total Funding
26
Number of Employees
$4M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Paris
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 26 | 30% | N/A |
#2 | $3.7M | 26 | -75% | N/A |
#3 | $2.6M | 26 | -30% | N/A |
#4 | $2.5M | 26 | -21% | N/A |
#5 | $4.6M | 26 | -4% | N/A |